The effects of kratom (Mitragyna speciosa) on metabolic syndrome-related parameters: a systematic review and meta-analysis
Frontiers in Pharmacology · 18.06.2025 · 16
DOI: 10.3389/fphar.2025.1587528 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Pharmacology, online erschienen am 18.06.2025. Verfasst von Ajaree Rayanakorn und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Mitragyna speciosa Korth. [Rubiaceae] is a tropical plant with opioid-like properties used for its metabolic altering effects, but data on the metabolic effects are lacking. This systematic review and meta-analysis aim to examine the effects of kratom use on parameters related to metabolic syndrome (MetS) in humans.
Methods
PubMed, Web of Science, Embase, and Cochrane Library databases were searched from inception to 6 September 2024 to identify eligible analytical studies examining the association between kratom consumption and metabolic effects. The effect estimates were summarized as mean differences (MDs) with 95% confidence intervals (CIs) and pooled using random-effects models.
Results
Five cross-sectional studies were included. The meta-analysis involving 1,458 adults observed significantly lower levels of serum low-density lipoprotein cholesterol (LDL-c) (MD -0.25-0.21 mmol/L; 95% CI: −0.39, −0.02), triglyceride (MD -0.17 mmol/L; 95% CI: −0.25, −0.09), while high-density lipoprotein cholesterol (HDL-c) levels increased (MD 0.07 mmol/L; 95% CI: 0.03, 0.11). Body mass index was also lower in adults using kratom when compared to the control group (MD -1.52 kg/m 2 ; 95% CI: −2.81, −0.23).
Conclusion
Kratom use in the adult population was associated with lower LDL-c, TG, BMI, and higher HDL-c levels. However, the total cholesterol and blood sugar lowering effects were not statistically significant. The findings suggest that kratom use may have a protective effect against certain metabolic risk factors. Further investigations particularly longitudinal studies with larger sample sizes are required to confirm these findings. Systematic Review Registration identifier CRD42024600702
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
- Clinical Research Center for Food and Herbal Product Trials and Development (CR-FAH), Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
- School of Pharmacy, Monash University Malaysia, Bandar Sunway, Malaysia.
- Office of Research Administration, Chiang Mai University, Chiang Mai, Thailand.
Zitieren
APA
Rayanakorn, A., Apisitwittaya, P., Lee, S. W. H., Yaja, K., Inpan, R., Na Takuathung, M., & Koonrungsesomboon, N. (2025). The effects of kratom (Mitragyna speciosa) on metabolic syndrome-related parameters: a systematic review and meta-analysis. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1587528
Vancouver
Rayanakorn A, Apisitwittaya P, Lee SWH, Yaja K, Inpan R, Na Takuathung M, et al. The effects of kratom (Mitragyna speciosa) on metabolic syndrome-related parameters: a systematic review and meta-analysis. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1587528
BibTeX
@article{Rayanakorn2025,
author = {Rayanakorn, Ajaree and Apisitwittaya, Pattarachon and Lee, Shaun Wen Huey and Yaja, Kantirat and Inpan, Ratchanon and Na Takuathung, Mingkwan and Koonrungsesomboon, Nut},
title = {The effects of kratom (Mitragyna speciosa) on metabolic syndrome-related parameters: a systematic review and meta-analysis},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1587528}
}
EUVIMED